Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Iopamidol
Drug ID BADD_D01181
Description Iopamidol is a contrast agent developed by Bracco with nonionic, low-osmolar properties.
Indications and Usage Not Available
Marketing Status approved
ATC Code V08AB04
DrugBank ID DB08947
KEGG ID D01797
MeSH ID D007479
PubChem ID 65492
TTD Drug ID D0O2HQ
NDC Product Code 68225-077; 0270-1412; 68225-078; 68225-100; 0270-1315; 0270-1317; 0270-1411; 70436-126; 62331-006; 0270-1316; 68225-076; 0270-1314; 70436-124; 57876-222
UNII JR13W81H44
Synonyms Iopamidol | Jopamidol | Gastromiro | Iopamidol, (+-)-Isomer | Iopamidol, (R)-Isomer | Iopamidol, Sodium Salt, (S)-Isomer | Iopamiro | Isovue 370 | Niopam | Solutrast | Solutrast 370 | Solutrast Gastro | SQ 13,396 | B-15,000 | B 15,000 | B15,000 | B-15000 | B 15000 | B15000 | Isovue
Chemical Information
Molecular Formula C17H22I3N3O8
CAS Registry Number 60166-93-0
SMILES CC(C(=O)NC1=C(C(=C(C(=C1I)C(=O)NC(CO)CO)I)C(=O)NC(CO)CO)I)O
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Blister23.03.01.001; 12.01.06.0020.015649%Not Available
Body temperature increased13.15.01.001--Not Available
Bradycardia02.03.02.0020.014227%Not Available
Bronchospasm22.03.01.004; 10.01.03.012--
Burning sensation17.02.06.001; 08.01.09.0290.007113%Not Available
Cardiac arrest02.03.04.0010.064020%
Cardiac failure02.05.01.001--
Cardio-respiratory arrest22.02.06.007; 02.03.04.0020.079670%Not Available
Cardiovascular disorder02.11.01.010; 24.03.02.009--Not Available
Cauda equina syndrome17.10.03.006--Not Available
Cerebral infarction24.04.06.002; 17.08.01.0040.007113%Not Available
Chest discomfort22.12.02.002; 08.01.08.019; 02.02.02.0090.059752%Not Available
Chest pain08.01.08.002; 02.02.02.011; 22.12.02.0030.064732%Not Available
Chills15.05.03.016; 08.01.09.0010.052639%
Choking22.12.03.003--Not Available
Circulatory collapse24.06.02.001--Not Available
Coma17.02.09.001--Not Available
Compartment syndrome24.04.05.006; 15.05.05.0050.010670%Not Available
Confusional state19.13.01.001; 17.02.03.005--
Conjunctival oedema06.04.01.001--Not Available
Conjunctivitis11.01.06.012; 06.04.01.002--
Contrast media reaction12.02.05.029; 10.01.01.0110.352824%Not Available
Conversion disorder19.24.01.0010.007113%Not Available
Coronary artery stenosis12.02.01.037; 24.04.04.017; 02.02.01.0100.007113%Not Available
Cough22.02.03.0010.112392%
Cyanosis22.02.02.007; 23.06.04.005; 02.11.04.004; 24.03.01.0070.014227%
Deafness04.02.01.001--Not Available
Depressed level of consciousness17.02.04.0020.029876%
Dermatitis23.03.04.002--Not Available
Dermatitis acneiform23.02.01.0040.007113%
The 2th Page    First    Pre   2 3 4 5 6    Next   Last    Total 10 Pages
ADReCS-Target
Drug Name ADR Term Target
Tip:  Drug Name  ADR Term  Protein  Variation  Gene